11 – 20 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Stem cell-derived dopamine cell therapies for Parkinson’s disease : what have the first trials shown?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Protocol for isolating nuclei from human stem cell-derived grafts for single-nucleus RNA sequencing
- Contribution to journal › Article
-
Mark
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids : Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery
- Contribution to journal › Article
- 2024
-
Mark
Modular 3D printed platform for fluidically connected human brain organoid culture
- Contribution to journal › Article
-
Mark
Expanding the therapeutic potential of neuro(active)steroids : a promising strategy for hyperdopaminergic behavioral phenotypes
- Contribution to journal › Scientific review
-
Mark
Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons
- Contribution to journal › Article
-
Mark
The history and status of dopamine cell therapies for Parkinson's disease
- Contribution to journal › Scientific review
-
Mark
The AAV-α-Synuclein Model of Parkinson's Disease : An Update
- Contribution to journal › Scientific review
-
Mark
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease
- Contribution to journal › Scientific review
-
Mark
Identification and validation of novel engineered AAV capsid variants targeting human glia
- Contribution to journal › Article
